Single cell genomics (SCG) is a fast growing, emerging approach in which
genomic technologies (i.e., that assess nucleic acids such as DNA or
RNA) are applied at the level of single cells, rather than at the level
of an entire cell population. The first edition of this report reviews
the market size, segmentation, growth and trends of the SCG market.

The author assesses the SCG market across 7 segments and 32 sub-segments:

For each of these segments, the author provides an estimated market size
and growth from 2009 to 2018, as well as key growth drivers and
moderators. In addition, we review key factors driving future growth
including 1) accelerating interest among scientists given a number of
applications that SCG can enable, 2) launch of new platforms that
streamline the historically laborious and low throughput workflow, 3)
development of new protocols and reagents optimized to improve the
amplification of DNA/RNA from single cells for downstream analysis and
5) adoption of SCG by new customers segments, most notably clinical
laboratories.

On the other hand, the author discusses several key factors moderating
growth including 1) remaining workflow challenges, including isolating
cells from tissue and recovering DNA / RNA at a high yield, amplifying
DNA / RNA with limited bias and downstream computational analysis, 2)
continued funding pressures for academic customers (currently
representing the majority of the market) particularly in the U.S. and
Europe. Special analysis conducted in this report includes the analysis
and categorization of -300 SCG publications published since 2007.

Research and Markets is the world's leading source for international
market research reports and market data. We provide you with the latest
data on international and regional markets, key industries, the top
companies, new products and the latest trends.